Page last updated: 2024-10-31

methiothepin and Cancer of Prostate

methiothepin has been researched along with Cancer of Prostate in 1 studies

Methiothepin: A serotonin receptor antagonist in the CENTRAL NERVOUS SYSTEM used as an antipsychotic.
methiothepin : A dibenzothiepine that is 10,11-dihydrodibenzo[b,f]thiepine bearing additional methylthio and 4-methylpiperazin-1-yl substituents at positions 8 and 10 respectively. Potent 5-HT2 antagonist, also active as 5-HT1 antagonist. Differentiates 5-HT1D sub-types. Also displays affinity for rodent 5-HT5B, 5-HT5A, 5-HT7 and 5-HT6 receptors (pK1 values are 6.6, 7.0, 8.4 and 8.7 respectively).

Research Excerpts

ExcerptRelevanceReference
"The development of prostate cancer independent of androgen is closely related to the action of neuroendocrine products."1.56Methiothepin mesylate causes apoptosis of human prostate cancer cells by mediating oxidative stress and mitochondrial dysfunction. ( Lim, W; Song, G; Yang, C, 2020)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Yang, C1
Song, G1
Lim, W1

Other Studies

1 other study available for methiothepin and Cancer of Prostate

ArticleYear
Methiothepin mesylate causes apoptosis of human prostate cancer cells by mediating oxidative stress and mitochondrial dysfunction.
    Free radical biology & medicine, 2020, Volume: 150

    Topics: Apoptosis; Cell Line, Tumor; Endoplasmic Reticulum Stress; Humans; Hydrogen Peroxide; Male; Membrane

2020